Human immunodeficiency virus (HIV), Hepatitis B (HBV) and Hepatitis C (HCV) are blood-
borne viruses with potentially shared routes of transmission. In high-income settings, the …

Background: Screening people living with HIV for hepatitis B virus (HBV) co-infection is
recommended in resource-rich settings to optimize HIV antiretroviral therapy (ART) and …

Background We assessed the effects of hepatitis B (HBV) or hepatitis C (HCV) co-infection
on outcomes of antiretroviral therapy (ART) in HIV-infected patients enrolled in the TREAT …

Background Comorbidity of irritable bowel syndrome (IBS) and psychiatric disorders is
common, and the prevalence of at least one psychiatric disorder has been reported as high …

Abstract Background. Hepatitis B virus (HBV) and human immunodeficiency virus (HIV)
coinfection has emerged as an important cause of morbidity and mortality. We determined …

AIM: To determine the rates and impact of hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections on response to long-term highly active antiretroviral therapy (HAART) in a …

Background: Hepatitis B and C viral co‑infections with human immunodeficiency virus (HIV)
are known to affect progression, management, and outcome of HIV infection. This study was …

Background: Despite declines in mortality and morbidity rates of patients with human
immunodeficiency virus (HIV) infection as the result of highly active antiretroviral therapy …

Background The immunologic status of a newly diagnosed HIV positive population in the era
of antiretroviral therapy in China has not been extensively evaluated. We conducted a cross …

Aim: Coinfection of HBV with HIV is associated with significant morbidity and mortality
globally. Despite increasing reports of HIV/HBV co-morbidities in Nigeria, little or no data …